Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoid X receptor beta (RXR-β) is a member of the retinoid X receptor family of nuclear receptors. It forms heterodimers with other nuclear receptors, such as RARs, PPARs, VDR and TRs and regulates gene transcription upon binding to specific DNA response elements. The primary endogenous ligand is 9-cis-retinoic acid. RXR-β plays roles in energy metabolism, immune responses, development, and skin health. It is ubiquitously expressed. Variants or altered function/expression have been linked to granulomatosis with polyangiitis and vasculitis.
Ligand binding induces a conformational change, promoting corepressor dissociation and coactivator recruitment, leading to altered gene transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoid X receptor beta.